6th Annual Ophthalmic Drugs 2023 Conference
Delving into advanced R&D and delivery of ocular therapeutics
6th Annual Ophthalmic Drugs 2023 Conference
Delving into advanced R&D and delivery of ocular therapeutics
SAE Media Group Conferences / SMi Group Ltd.
Ground Floor, India House, 45 Curlew Street, London, SE1 2ND
United Kingdom
Tel.: +44 (0)20 7827 6000
-
Basisinformation
Datum20.11.2023 - 21.11.2023TagungLondonSpracheEnglischGebühren ab1999.00 GBPVeranstalterSMi Group Ltd.
OrganisatorSAE Media Group Conferences / SMi Group Ltd.
Ground Floor, India House, 45 Curlew Street, London, SE1 2ND
United Kingdom
Tel.: +44 (0)20 7827 6000 -
VERANSTALTUNGSORT
Copthorne Tara Hotel London
Scarsdale Place
W8 5SR London, GB -
Programm
Benefits attending:
- Assess new industry directions through the latest data from ophthalmic clinical trials
- Review advanced techniques in treating age-related diseases of ophthalmology
- Explore evolving therapeutic potential in undruggable diseases through innovative gene therapies
- Examine novel methodologies in delivery technologies being used to further the ophthalmic therapeutic field
- Engage in the regulatory landscape of ophthalmic drugs and key considerations for R&D
who should attend:
- Heads and VPs of Retinal Health, Ocular Therapy, Medical Safety, and Ophthalmology.
- Professors, Senior Lecturers, and Specialists in Ocular biology and immunology, and clinical pharmaceuticals.
- CEOs, CMOs and Researchers from pharmaceutical companies involved in ocular drug development, in addition to biotechnologies involved in ocular drug delivery research.
Aerie Pharmaceuticals; Alcon Management SA; Boehringer Ingelheim Biopharmaceuticals Gmbh; Carl Zeiss AG; Centro de Oftamologia Barraquer; Experimentica Ltd; Eyenuk; Global Ophthamology R&D, Santen Inc, USA; Graybug Vision Inc; iVeena; Iveric Bio; Kingston University; Kingston University London; Medicines & Healthcare products Regulatory Agency (MHRA); Medivis; MedPharm Ltd; MHRA; Nanoptima Ltd; Newcastle University; Novartis Pharmaceutical inc; Ophthalmic Drugs 2019; Ophthalmology Times Europe; Optceutics Ltd; ProMed Pharma, LLC; ProQR Therapeutics; RAFARM S.A. Pharmaceuticals; Roche; Roche Products Limited; Santen UK; Spark Therapeutics; Thea Open Innovation; Topivert; twoXAR; UCL Institute of Ophthalmology; UCL School of Pharmacy and UCL Institute of Ophthalmology; University of Oxford; University of Reading; University of Strathclyde;
Unfortunately, we do not yet have the detailed scientific program. We are continuing our research.
-
Gebühren
Fachärzte/-innenGebühren ab1.999,00 GBPIndustriemitarbeiter/-innenGebühren ab1.999,00 GBP
-
Buchung / Anmeldung
Registration required. Please contact the organizer for further information.
-
Zertifizierung
Keine Zertifizierung beantragt
-
Sponsoren
Experimentica Ltd.Promed Pharma